A compilation of bioinformatic approaches to identify novel downstream targets for the detection and prophylaxis of cancer

Adv Protein Chem Struct Biol. 2023:134:75-113. doi: 10.1016/bs.apcsb.2022.11.015. Epub 2023 Feb 18.

Abstract

The paradigm of cancer genomics has been radically changed by the development in next-generation sequencing (NGS) technologies making it possible to envisage individualized treatment based on tumor and stromal cells genome in a clinical setting within a short timeframe. The abundance of data has led to new avenues for studying coordinated alterations that impair biological processes, which in turn has increased the demand for bioinformatic tools for pathway analysis. While most of this work has been concentrated on optimizing certain algorithms to obtain quicker and more accurate results. Large volumes of these existing algorithm-based data are difficult for the biologists and clinicians to access, download and reanalyze them. In the present study, we have listed the bioinformatics algorithms and user-friendly graphical user interface (GUI) tools that enable code-independent analysis of big data without compromising the quality and time. We have also described the advantages and drawbacks of each of these platforms. Additionally, we emphasize the importance of creating new, more user-friendly solutions to provide better access to open data and talk about relevant problems like data sharing and patient privacy.

Keywords: Bioinformatics; Downstream targets; Pathway analysis; RNAseq analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Big Data
  • Computational Biology*
  • Genomics
  • Humans
  • Neoplasms*